Showing results (191-200 of 323) with videos related to

Sort By:
Pageof 33
Urology|March 1, 1995
Interleukin-6: a candidate mediator of human prostate cancer morbidityD A Twillie, M A Eisenberger, M A Carducci, et al.
Biochemistry|December 16, 1997
Dissecting the catalytic mechanism of staphylococcal lipases using carbamate substrates: chain length selectivity, interfacial activation, and cofactor dependenceJ W Simons, J W Boots, M P Kats, et al.
Photochemistry and Photobiology|April 1, 1994
The UV action spectra for the clone-forming ability of cultured human melanocytes and keratinocytesS M de Leeuw, S Janssen, J W Simons, et al.
Oncogene|March 1, 2005
Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cellsCeshi Chen, Xiaodong Sun, Qimei Ran, et al.
Molecular & General Genetics : MGG|August 1, 1992
Stress response induced by DNA damage leads to specific, delayed and untargeted mutationsJ J Boesen, S Stuivenberg, C H Thyssens, et al.
Mutagenesis|July 1, 1992
A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchangesM Z Zdzienicka, G P van der Schans, A T Natarajan, et al.
Translational Psychiatry|July 23, 2025
Pharmacologic and genetic evidence converge on mechanisms of psychotic illnessBrian Fennessy, Liam Cotter, Nicole W Simons, et al.
Cancer Research|April 5, 2000
Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeuticsH Zhong, K Chiles, D Feldser, et al.
BJU International|December 24, 2010
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicityAshley E Ross, Ashkan Emadi, Luigi Marchionni, et al.
Oncotarget|July 5, 2012
Sox9 is required for prostate development and prostate cancer initiationZhenhua Huang, Paula J Hurley, Brian W Simons, et al.
Pageof 33